D5BH:XETRA:XETRA-Xtrackers MSCI Canada ESG Screened UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 77.58

Change

-0.53 (-0.68)%

Market Cap

USD 0.36B

Volume

864.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B

ETFs Containing D5BH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.63% 71% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.63% 71% C- 70% C-
Trailing 12 Months  
Capital Gain 25.11% 77% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.11% 77% C+ 75% C
Trailing 5 Years  
Capital Gain 61.39% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.39% 74% C 72% C
Average Annual (5 Year Horizon)  
Capital Gain 11.82% N/A N/A 75% C
Dividend Return 11.82% N/A N/A 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.21% N/A N/A 39% F
Risk Adjusted Return 68.67% N/A N/A 71% C-
Market Capitalization 0.36B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike